Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

4724 ARTÍCULOS , VIENDO DEL 1606 AL 1620

The Link between Gaucher Disease and Parkinson's Disease Sheds Light on Old and Novel Disorders of Sphingolipid Metabolism

Indellicato R, Trinchera M.

Int J Mol Sci. 2019 Jul 5;20(13):3304. doi: 10.3390/ijms20133304.

Non-Skeletal Activities of Vitamin D: From Physiology to Brain Pathology

Bivona G, Agnello L, Bellia C, Iacolino G, Scazzone C, Lo Sasso B, Ciaccio M.

Medicina (Kaunas). 2019 Jul 5;55(7):341. doi: 10.3390/medicina55070341.

PET Imaging of Adenosine Receptors in Diseases

Li J, Hong X, Li G, Conti PS, Zhang X, Chen K.

Curr Top Med Chem. 2019;19(16):1445-1463. doi: 10.2174/1568026619666190708163407.

Targeting the PAC1 Receptor for Neurological and Metabolic Disorders

Liao C, de Molliens MP, Schneebeli ST, Brewer M, Song G, Chatenet D, Braas KM, May V, Li J.

Curr Top Med Chem. 2019;19(16):1399-1417. doi: 10.2174/1568026619666190709092647.

Systematic review of neuropsychological instruments used in subthalamic nucleus deep brain stimulation in Parkinson´s disease patients

Barbosa ENBE, Charchat-Fichman H.

Dement Neuropsychol. 2019 Apr-Jun;13(2):162-171. doi: 10.1590/1980-57642018dn13-020004.

Deep Brain Stimulation in Patients With Mutations in Parkinson's Disease-Related Genes: A Systematic Review

de Oliveira LM, Barbosa ER, Aquino CC, Munhoz RP, Fasano A, Cury RG.

Mov Disord Clin Pract. 2019 Jun 19;6(5):359-368. doi: 10.1002/mdc3.12795. eCollection 2019 Jun.

Abnormal DaTSCAN and Atypical Parkinsonism in SCA12

Latorre A, Del Gamba C, Menozzi E, Balint B, Brugger F, Bhatia KP.

Mov Disord Clin Pract. 2019 Mar 28;6(5):400-402. doi: 10.1002/mdc3.12751. eCollection 2019 Jun.

Neuroprotective Effects of Brain-Gut Peptides: A Potential Therapy for Parkinson's Disease

Dong D, Xie J, Wang J.

Neurosci Bull. 2019 Dec;35(6):1085-1096. doi: 10.1007/s12264-019-00407-3. Epub 2019 Jul 8.

Does transcranial direct current stimulation improve functional locomotion in people with Parkinson's disease? A systematic review and meta-analysis

Lee HK, Ahn SJ, Shin YM, Kang N, Cauraugh JH.

J Neuroeng Rehabil. 2019 Jul 8;16(1):84. doi: 10.1186/s12984-019-0562-4.

Role of the endolysosomal system in Parkinson's disease

Vidyadhara DJ, Lee JE, Chandra SS.

J Neurochem. 2019 Sep;150(5):487-506. doi: 10.1111/jnc.14820. Epub 2019 Jul 31.

Can GBA1-Associated Parkinson Disease Be Modeled in the Mouse?

Farfel-Becker T, Do J, Tayebi N, Sidransky E.

Trends Neurosci. 2019 Sep;42(9):631-643. doi: 10.1016/j.tins.2019.05.010. Epub 2019 Jul 6.

Minor hallucinations in Parkinson disease: A subtle symptom with major clinical implications

Lenka A, Pagonabarraga J, Pal PK, Bejr-Kasem H, Kulisevsky J.

Neurology. 2019 Aug 6;93(6):259-266. doi: 10.1212/WNL.0000000000007913. Epub 2019 Jul 9.

Diagnosis and Management of Autonomic Dysfunction in Dementia Syndromes

Allan LM.

Curr Treat Options Neurol. 2019 Jul 10;21(8):38. doi: 10.1007/s11940-019-0581-2.

The challenge of pain in the pharmacological management of Parkinson's disease

Jost WH, Buhmann C.

Expert Opin Pharmacother. 2019 Oct;20(15):1847-1854. doi: 10.1080/14656566.2019.1639672. Epub 2019 Jul 10.

The locus coeruleus: Another vulnerability target in Parkinson's disease

Oertel WH, Henrich MT, Janzen A, Geibl FF.

Mov Disord. 2019 Oct;34(10):1423-1429. doi: 10.1002/mds.27785. Epub 2019 Jul 10.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias